SCHEMBL4433136

SCHEMBL4433136

Cc1c[nH]c2ccc(N(CC(=O)O)S(=O)(=O)c3cc(Cl)cc(Cl)c3)cc12

nearest known ligand 0.46

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 12/20 0.46
NFE2L2 Q16236 12/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
TP53 P04637 1/20 0.44
PPARG P37231 1/20 0.39
ALDH1A1 P00352 1/20 0.39
HCRTR2 O43614 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4434288 0.89 TP53 (0.43) KEAP1NFE2L2SMN1; SMN2TP53ALDH1A1
SCHEMBL10317101 0.88 HTR6 (0.44) KEAP1NFE2L2SMN1; SMN2TP53ALDH1A1
SCHEMBL4435081 0.87 TP53 (0.42) KEAP1NFE2L2SMN1; SMN2TP53ALDH1A1
SCHEMBL13390171 0.86 RAB9A (0.37) KEAP1NFE2L2TP53ALDH1A1HCRTR2
SCHEMBL4438874 0.83 SMN1; SMN2 (0.48) KEAP1NFE2L2SMN1; SMN2TP53PPARG
SCHEMBL2843641 0.83 KEAP1 (0.46) KEAP1NFE2L2SMN1; SMN2TP53PPARG
SCHEMBL2848207 0.80 KEAP1 (0.41) KEAP1NFE2L2SMN1; SMN2TP53ALDH1A1
SCHEMBL2846006 0.80 PLAU (0.41) KEAP1NFE2L2SMN1; SMN2TP53ALDH1A1
SCHEMBL2842356 0.79 KEAP1 (0.40) KEAP1NFE2L2SMN1; SMN2TP53ALDH1A1
SCHEMBL4428459 0.79 TP53 (0.47) KEAP1NFE2L2SMN1; SMN2TP53PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2121600-B1 SUBSTITUTED ARYLSULPHONYLGLYCINES, THE PREPARATION THEREOF AND THE USE THEREOF AS PHARMACEUTICAL COMPOSITIONS BOEHRINGER INGELHEIM INT (DE) 2012-07-18 EP disclosed
EP-2121600-A2 SUBSTITUTED ARYLSULPHONYLGLYCINES, THE PREPARATION THEREOF AND THE USE THEREOF AS PHARMACEUTICAL COMPOSITIONS Boehringer Ingelheim International GmbH (DE) 2009-11-25 EP disclosed
WO-2008099000-A2 SUBSTITUTED ARYLSULPHONYLGLYCINES, THE PREPARATION THEREOF AND THE USE THEREOF AS PHARMACEUTICAL COMPOSITIONS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-08-21 WO disclosed